Results 151 to 160 of about 2,285,924 (374)

Next‐generation morphology, a novel multilayer morphometric digital analysis, reveals both the basic topology and new trends of myelodysplasia of peripheral blood specimens

British Journal of Haematology, EarlyView.
Current digital microscopy compromises between resolution and field of view, hence limiting its performance. Next‐generation morphology (NGM) is a novel five‐layer analytical approach (Left, top) leveraging a physical solution (Left, bottom) that enables high‐resolution, large‐field digital imaging, data mining and analysis of blood specimens.
Ben‐Zion Katz, Yakir Moshe, Dan Bensity, Efrat Luttwak, Merav Brazilai, Howard S. Oster, Olga Pozdnyakova, Moshe Mittelman, Irit Avivi   +8 more
wiley   +1 more source

Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemic progression from myelodysplastic syndrome [PDF]

, 1988
H Hirai, Mitsuru Okada, Hajime Mizoguchi, Hironori Mano, Yukio Kobayashi, Junji Nishida, F Takaku   +6 more
openalex   +1 more source

Pyogenic abscesses in the myelodysplastic syndrome. [PDF]

, 1989
Patrick Williamson, David Oscier, G J Mufti, Terry J. Hamblin   +3 more
openalex   +1 more source

Efficacy of ciclosporin monotherapy in non‐severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study

British Journal of Haematology, EarlyView.
Summary The efficacy of ciclosporin (CsA) to treat transfusion‐independent non‐severe aplastic anaemia (TI‐NSAA) has not yet been systematically evaluated. We conducted a prospective trial in patients with TI‐NSAA treated with CsA monotherapy. CsA (3.5 mg/kg/day) was administered to patients with TI‐NSAA aged ≥16.
Ken Ishiyama, Masahide Yamazaki, Hiroyuki Maruyama, Naoko Hosono, Hiroki Yamaguchi, Noboru Asada, Kazuki Tanimoto, Hiroyuki Sugiura, Kensuke Usuki, Kenichi Yoshimura, Seishi Ogawa, Yuzuru Kanakura, Itaru Matsumura, Koichi Akashi, Shinji Nakao   +14 more
wiley   +1 more source

Using Artificial Intelligence to Enhance Myelodysplastic Syndrome Diagnosis, Prognosis, and Treatment

Biomedicines
Myelodysplastic syndromes represent a group of hematological neoplastic diseases caused by defective stem cells causing cytopenia and abnormal hematopoiesis. More than 30% of myelodysplastic syndrome cases develop into acute myeloid leukemia. An analysis
Fabio Stagno, Giuseppe Mirabile, Patricia Rizzotti, Adele Bottaro, Antonio Pagana, Sebastiano Gangemi, Alessandro Allegra   +6 more
doaj   +1 more source

Mutations of N‐ras Oncogene in Myelodysplastic Syndromes and Lcukemias Detected by Polymerase Chain Reaction [PDF]

, 1989
Hiroyuki Mano, Fuyuki Ishikawa, Hisamaru Hirai, Fumimaro Takaku   +3 more
openalex   +1 more source

Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid‐refractory acute graft‐versus‐host disease treatment

British Journal of Haematology, EarlyView.
Summary Steroid‐refractory acute graft‐versus‐host disease (SR‐aGvHD) remains a significant challenge after haematopoietic cell transplantation (HCT). While ruxolitinib (RUX) has shown efficacy for SR‐aGvHD, failure predictors are poorly defined. We assessed 78 patients from six Canadian centres who received RUX for SR‐aGvHD. Failure‐free survival (FFS)
Sergio Rodriguez‐Rodriguez, Nihar Desai, Carol Chen, Kareem Jamani, Catherine Sohier‐Poirier, Christopher Lemieux, Jennifer White, Mohamed Elemary, Michael Kennah, Tommy Alfaro Moya, Eshrak Al‐Shaibani, Igor Novitzky‐Basso, Ivan Pasic, Arjun Datt Law, Fotios V. Michelis, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim   +18 more
wiley   +1 more source

Validation of survival‐predictive models in myelodysplastic syndromes [PDF]

, 1989
Miguel Á. Sanz, José Ignacio Leal Lorenzo, Guillermo Sanz, Sonia García-Merino, Victoria Amigó, Teresa Vallespı́, Marta Torrabadella, M.C. Cañizo, Jesús F. San Miguel   +8 more
openalex   +1 more source

The diagnostic performance of the basic versus the detailed telomere Flow FISH test in young patients with aplastic anaemia

British Journal of Haematology, EarlyView.
Summary Identifying telomere biology disorders (TBDs) in patients with aplastic anaemia (AA) is essential for guiding appropriate care. Telomere length (TL) measurement by flow cytometry with fluorescence in situ hybridization supports diagnosis, but the real‐world performance of the basic test (lymphocytes and granulocytes) versus the detailed test ...
Nicholas F. DeCleene, Duc T. Nguyen, Susan E. Kirk, Hannah L. Helber, Ghadir S. Sasa, Alison A. Bertuch   +5 more
wiley   +1 more source

Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress [editorial] [PDF]

, 1994
RM Stone
openalex   +3 more sources